Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL
about
Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea(-)-Epigallocatechin-3-Gallate Enhances Hepatitis C Virus Double-Stranded RNA Intermediates-Triggered Innate Immune Responses in Hepatocytes.Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial.Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease.Natural and synthetic antioxidants: an updated overview.(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia.Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs.
P2860
Q26852556-828113F7-2E8F-414B-A74D-2784CAAEA965Q27346473-7A968309-C545-4F03-9BA1-0F45BF775078Q35116119-4E0BD237-4F5E-418D-B225-93B893B05AC7Q36536256-C1CCC79D-3116-40E0-8DF5-0275EA57EA14Q37788234-2D72B9C4-8D0A-4501-872E-ABFBFC3BD0D2Q39439105-A6F729E0-E59E-4CB3-B4B0-2BF3500E54F6Q41608489-628FDDB5-DE33-440F-8C4E-2945CFFD3370Q41679554-3722C9E5-9462-44B3-9666-F7E7C82B7B2BQ46871021-2E46E715-AE3C-4C9B-8BE5-D6B5C6FC4EBE
P2860
Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL
description
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Januar 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/01/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/01/01)
@nl
наукова стаття, опублікована в січні 2006
@uk
مقالة علمية (نشرت عام 2006)
@ar
name
Epigallocatechin gallate incre ...... the secretion of apoB-100 VLDL
@ast
Epigallocatechin gallate incre ...... the secretion of apoB-100 VLDL
@en
Epigallocatechin gallate incre ...... the secretion of apoB-100 VLDL
@nl
type
label
Epigallocatechin gallate incre ...... the secretion of apoB-100 VLDL
@ast
Epigallocatechin gallate incre ...... the secretion of apoB-100 VLDL
@en
Epigallocatechin gallate incre ...... the secretion of apoB-100 VLDL
@nl
prefLabel
Epigallocatechin gallate incre ...... the secretion of apoB-100 VLDL
@ast
Epigallocatechin gallate incre ...... the secretion of apoB-100 VLDL
@en
Epigallocatechin gallate incre ...... the secretion of apoB-100 VLDL
@nl
P2093
P2860
P1476
Epigallocatechin gallate incre ...... the secretion of apoB-100 VLDL
@en
P2093
Anna Ljungberg
Björn Magnusson
Caroline Beck
Denis Marchesan
Johanna Ericsson
Linda Andersson
Mikael Rutberg
Pia Stillemark-Billton
Pontus Boström
P2860
P356
10.1194/JLR.M500424-JLR200
P577
2006-01-01T00:00:00Z